Activating c-kit gene mutations in human germ cell tumors.

The c-kit gene encodes a tyrosine kinase receptor (KIT) that is required in normal spermatogenesis and is expressed in seminomas and dysgerminomas, a subset of human germ cell tumors (GCTs). To determine whether activating mutations of the c-kit gene occur in GCTs, primary tissue samples of 33 testicular and ovarian tumors were examined for mutations in the juxtamembrane and phosphotransferase domains by polymerase chain reaction amplification and DNA sequencing. A novel missense mutation (D816H) was found in the phosphotransferase domain in tumors of seminoma/dysgerminoma differentiation. The c-kit alleles in nonneoplastic tissues from these patients were wild type, suggesting that the mutant alleles were acquired and selected for during malignant transformation. In cell transfection experiments, the D816H mutant protein was a constitutively activated kinase and was constitutively phosphorylated on tyrosine residues. This is the first description of an activating c-kit mutation in GCTs and is evidence that the KIT signal transduction pathway is important in the pathogenesis of neoplasms with seminoma differentiation.

[1]  Laura H. Tang,et al.  Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm , 1996, Nature Genetics.

[2]  D. Metcalfe,et al.  The protooncogene c-kit and c-kit ligand in human disease. , 1997, The Journal of allergy and clinical immunology.

[3]  S. Elledge,et al.  Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis , 1995, The Journal of experimental medicine.

[4]  K. Loveland,et al.  Stem cell factor and c-kit in the mammalian testis: lessons originating from Mother Nature's gene knockouts. , 1997, The Journal of endocrinology.

[5]  G. Krystal,et al.  Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. , 1996, Cancer research.

[6]  R. Weller,et al.  International Histological Classification of Tumours , 1981 .

[7]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[8]  S. Sternberg,et al.  Diagnostic surgical pathology , 1994 .

[9]  G. Krystal,et al.  Coexpression of the c-kit and stem cell factor genes in breast carcinomas. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[10]  N. Leslie,et al.  An activating mutation in the kit receptor abolishes the stroma requirement for growth of ELM erythroleukemia cells, but does not prevent their differentiation in response to erythropoietin. , 1998, Blood.

[11]  C. Marshall,et al.  Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors , 1999, Oncogene.

[12]  D. Slamon,et al.  Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. , 1995, The Journal of urology.

[13]  S. Hirota,et al.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. , 1998, Science.

[14]  R. Chaganti,et al.  A genetic perspective of male germ cell tumors. , 1998, Seminars in oncology.

[15]  Y. Suzuki,et al.  Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Moskaluk,et al.  Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. , 1997, The American journal of pathology.

[17]  Y. Kitamura,et al.  Mechanisms of constitutive activation of c-kit receptor tyrosine kinase. , 1997, Leukemia.